Welcome to KBC Securities
We believe banking is a craft, not an art or a science. As the integrated Equity
House of KBC Group, we combine specialist expertise, skill and personal commitment
to bring lasting value to our clients and people.
More about us
Collapse research area
- Benelux Morning Note24 jun 2016
- Benelux Morning Note23 jun 2016
Beter Bed Holding: M-line brand will be distributed in UK by Dreams
Celyad: First patient of 4th dose level of NKR-2 treated
Colruyt: Feedback analyst meeting – FY15/16
MDxHealth: Expansion of ConfirmMDx reimbursement cove ...
- Benelux Morning Note22 jun 2016
ASIT biotech: Large scale manufacturing lead product secured
Barco: Two nice contracts
Colruyt: Soft results do not warrant such a premium
Kinepolis: The first all-laser cinema in Breda
- ASIT BIOTECH: Tackling allergies at the root - Initiation of coverage21 jun 2016
ASIT Biotech is a clinical-stage biopharmaceutical company focused on the development and future commercialisation of a range of immunotherapy products for the treatment of allergies.
- BREXIT OR BREMAIN?21 jun 2016
As 23 June approaches, stock markets have been getting increasingly jittery and volatility is high, as sentiment swings from ‘Brexit to ‘Bremain’ and back.
- Benelux Morning Note21 jun 2016
ASIT biotech: Tackling allergies at the root
Beter Bed Holding: Closes Sängjätten acquisition
Biocartis: Important Lung panel assay launched
Heineken: Nigerian Naira drops as government lifts pegs
Immobel: Important miles ...
- Benelux Morning Note20 jun 2016
- Benelux Morning Note17 jun 2016